Stable Angina Management and Treatment

NCT03781492 · tracked via the Priya Life Science Poland tracker

Sponsor

Silesian Centre for Heart Diseases

Phase

Observational

Started

2006-01-01

Last updated

2020-05-26

Condition(s) studied

Stable AnginaCoronary Artery Disease

Study summary

The Prospective REgistry of Stable Angina manaGEment and Treatment (PRESAGE) is an observational study on an all-comer stable angina population hospitalised in a highly specialized cardiovascular centre with cardiac surgery facilities. The aim of the study is to assess the clinical characteristics, treatment modalities, early and long-term outcomes in this population.

Eligibility

Sex

ALL

Min age

18 Years

Max age

—

Healthy volunteers

Inclusion Criteria: * symptom based diagnosis of stable angina Exclusion Criteria: * acute coronary syndrome on admission * ≤ 18 years old

Primary outcome measure(s)

Number of participants with reported deaths from any cause — From date of inclusion until the date of death from any cause, assessed up to 5 year

Trial sites (1)

Facility	City	Region	Status
3rd Chair and Department of Cardiology of Silesian Centre for Heart Diseases	Zabrze	Silesian Voivodeship	Recruiting

More Silesian Centre for Heart Diseases trials in Poland

Cerebral Protection in Transcatheter Left Atrial Appendage Occlusion Recruiting

Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM) Recruiting

Other trials for the same condition

Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold System in the Treatment of Subjects With Long de Novo Lesions Recruiting

COronoary Microcirculation Analysis NETwork Recruiting

Distal Evaluation of Functional Performance with Intravascular Sensors to Assess the Narrowing Effect: Guided Physiologic Stenting Enrolling by invitation

INSIGHTFUL-FFR Clinical Trial Recruiting

First in Men Study: BIOMAG-I Active, not recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03781492 on ClinicalTrials.gov ↗ ← All trials in Poland